OncoVista Innovative Therapies, Inc.
OVIT
Rank in Stocks
#34818
OncoVista Innovative Therapies, Inc. does not have significant business.... OncoVista Innovative Therapies, Inc. does not have significant business. Previously, it engaged in development of targeted anticancer therapies by utilizing tumor-associated biomarkers. The company was founded in 2004 and is based in San Antonio, Texas.
Share Price
$0.0001
Last synced: 2026-11-10
Market Cap
$2.31K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade OncoVista Innovative Therapies, Inc. (OVIT)
Category
Healthcare
EPS for OncoVista Innovative Therapies, Inc. (OVIT)
EPS as of September 2015 TTM: $-0.14
According to OncoVista Innovative Therapies, Inc.'s latest financial reports, its current EPS (TTM) is $-0.14. At the end of 2014 the company had an EPS of $-0.12, a decrease compared to its 2013 EPS of $-0.07.
EPS history for OncoVista Innovative Therapies, Inc. from 2004 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.14 | 16.67% |
| 2014 | $-0.12 | 71.43% |
| 2013 | $-0.07 | -12.50% |
| 2012 | $-0.08 | -20.00% |
| 2011 | $-0.10 | -9.09% |
| 2010 | $-0.11 | -57.69% |
| 2009 | $-0.26 | -36.59% |
| 2008 | $-0.41 | 24.24% |
| 2007 | $-0.33 | -35.29% |
| 2006 | $-0.51 | 3,542.86% |
| 2005 | $-0.01 | -48.34% |
| 2004 | $-0.03 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $-0.99 | 607.14% |
US
|
|
| $15.66 | -11,285.71% |
US
|
|
| $-7.07 | 4,950.00% |
US
|
|
| $-5.29 | 3,678.57% |
AU
|
|
| $12.88 | -9,300.07% |
BE
|
Questions about OncoVista Innovative Therapies, Inc.'s earnings per share (EPS)
What is OncoVista Innovative Therapies, Inc.'s earnings per share (EPS)?
OncoVista Innovative Therapies, Inc.'s earnings per share (EPS) over the last twelve months is $-0.14, as of Sep 2015.
What was OncoVista Innovative Therapies, Inc.'s earnings per share (EPS) in 2014?
In 2014, OncoVista Innovative Therapies, Inc.'s earnings per share (EPS) was $-0.12, compared with $-0.07 in 2013.
How has OncoVista Innovative Therapies, Inc.'s earnings per share (EPS) changed since 2009?
From 2009 to 2014, OncoVista Innovative Therapies, Inc.'s earnings per share (EPS) was highest in 2013 ($-0.07) and lowest in 2009 ($-0.26).
How does OncoVista Innovative Therapies, Inc.'s earnings per share (EPS) compare with similar companies?
OncoVista Innovative Therapies, Inc.'s earnings per share (EPS) ($-0.14) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.